Barry Quart
Vorstandsvorsitzender bei CONNECT BIOPHARMA HOLDINGS LIMITED
Vermögen: 836 740 $ am 31.05.2024
Aktive Positionen von Barry Quart
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| KINIKSA PHARMACEUTICALS, LTD. | Direktor/Vorstandsmitglied | 01.10.2015 | - |
| Independent Dir/Board Member | 01.10.2015 | - | |
| CONNECT BIOPHARMA HOLDINGS LIMITED | Direktor/Vorstandsmitglied | 12.06.2024 | - |
| Vorstandsvorsitzender | 12.06.2024 | - | |
NeuroGenetic Pharmaceuticals, Inc.
 NeuroGenetic Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NeuroGenetic Pharmaceuticals, Inc. discovers and develops drugs for the prevention of neurodegenerative conditions. The company was founded by William T. Comer, Rudy Tanzi and Steven L. Wagner in 2009 and is headquartered in Del Mar, CA. | Direktor/Vorstandsmitglied | - | - |
Kiniksa Pharmaceuticals Corp.
 Kiniksa Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Part of Kiniksa Pharmaceuticals Ltd., Kiniksa Pharmaceuticals Corp. is a clinical-stage biopharmaceutical company that develops and commercializes therapeutic medicines for patients suffering from debilitating diseases. The company is based in Lexington, MA. The CEO of the company is Sanj K. Patel. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Barry Quart
Ehemalige bekannte Positionen von Barry Quart
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| HERON THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 21.06.2012 | 13.10.2020 |
| Vorstandsvorsitzender | 02.05.2013 | 03.04.2023 | |
| Vorsitzender | 13.10.2020 | 03.04.2023 | |
| Präsident | 05.02.2019 | 13.10.2020 | |
| SYNAGEVA BIOPHARMA CORP | Direktor/Vorstandsmitglied | 01.06.2012 | 22.06.2015 |
| Independent Dir/Board Member | 01.06.2012 | 22.06.2015 | |
Ardea Biosciences, Inc.
 Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ardea Biosciences, Inc. is a biotechnology company which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. The company was founded in January 1994 and is headquartered in Wilmington, DE. | Direktor/Vorstandsmitglied | 01.06.2012 | 01.05.2013 |
| Vorstandsvorsitzender | 21.12.2006 | 01.05.2013 | |
| Gründer | 21.12.2006 | 01.05.2013 | |
| Präsident | 21.12.2006 | 01.05.2013 | |
Trimeris, Inc.
 Trimeris, Inc. Pharmaceuticals: MajorHealth Technology Trimeris, Inc. develops therapeutics for viral diseases. It is a biopharmaceutical company engaged in the discovery, development and commercialization of novel therapeutic agents for the treatment of viral disease. The core technology platform of fusion inhibition is based on blocking viral entry into host cells. The company was founded in 1993 and is headquartered in Durham, NC. | Direktor/Vorstandsmitglied | 27.06.2007 | 04.11.2011 |
Napo Pharmaceuticals, Inc.
 Napo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Napo Pharmaceuticals, Inc. provides pharmaceutical products for gastro-intestinal disorders. The company was founded by Lisa A. Conte in November 2001 and is headquartered in San Francisco, CA. | Präsident | 01.01.2002 | 01.12.2006 |
| ░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
| ░░░░░░░ ░░░░░░░░░░░░░░░ ░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░ ░░░ ░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
| ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | - |
Ausbildung von Barry Quart
| The University of California, San Francisco | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 14 |
Operativ
| Director/Board Member | 9 |
| Chief Executive Officer | 3 |
| President | 3 |
Sektoral
| Health Technology | 12 |
| Consumer Services | 2 |
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| HERON THERAPEUTICS, INC. | Health Technology |
| PFIZER, INC. | Health Technology |
| KINIKSA PHARMACEUTICALS, LTD. | Health Technology |
| CONNECT BIOPHARMA HOLDINGS LIMITED | Health Technology |
| Private Unternehmen | 8 |
|---|---|
Ardea Biosciences, Inc.
Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ardea Biosciences, Inc. is a biotechnology company which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. The company was founded in January 1994 and is headquartered in Wilmington, DE. | Health Technology |
Trimeris, Inc.
Trimeris, Inc. Pharmaceuticals: MajorHealth Technology Trimeris, Inc. develops therapeutics for viral diseases. It is a biopharmaceutical company engaged in the discovery, development and commercialization of novel therapeutic agents for the treatment of viral disease. The core technology platform of fusion inhibition is based on blocking viral entry into host cells. The company was founded in 1993 and is headquartered in Durham, NC. | Health Technology |
Napo Pharmaceuticals, Inc.
Napo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Napo Pharmaceuticals, Inc. provides pharmaceutical products for gastro-intestinal disorders. The company was founded by Lisa A. Conte in November 2001 and is headquartered in San Francisco, CA. | Health Technology |
Pfizer (La Jolla)
 Pfizer (La Jolla) Miscellaneous Commercial ServicesCommercial Services Part of Pfizer Inc., Pfizer (La Jolla) is a company that provides research services. The company is based in San Diego, CA. The company was founded by Michael R. Jirousek. | Commercial Services |
Agouron Pharmaceuticals LLC
 Agouron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Agouron Pharmaceuticals LLC develops and distributes therapeutic products. It provides therapeutic products which are used in the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, inflammatory diseases, respiratory diseases, infectious diseases, immunological disorders, pharmaceutical preparations and other diseases. The company was founded in 1984 and is headquartered in San Diego, CA. | Health Technology |
Synageva BioPharma Corp.
 Synageva BioPharma Corp. BiotechnologyHealth Technology Synageva BioPharma Corp. is a biopharmaceutical company which focuses on the discovery, development, and commercialization of therapeutic products for patients with life-threatening rare diseases and high unmet medical need. The company is currently evaluating sebelipase alfa in global clinical trials for LAL Deficiency, a lysosomal storage disease associated with liver damage and accelerated atherosclerosis in children and adults, and in infants, premature death often before six months of age. Synageva BioPharma was founded in 1993 and is headquartered in Lexington, MA. | Health Technology |
NeuroGenetic Pharmaceuticals, Inc.
NeuroGenetic Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NeuroGenetic Pharmaceuticals, Inc. discovers and develops drugs for the prevention of neurodegenerative conditions. The company was founded by William T. Comer, Rudy Tanzi and Steven L. Wagner in 2009 and is headquartered in Del Mar, CA. | Health Technology |
Kiniksa Pharmaceuticals Corp.
Kiniksa Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Part of Kiniksa Pharmaceuticals Ltd., Kiniksa Pharmaceuticals Corp. is a clinical-stage biopharmaceutical company that develops and commercializes therapeutic medicines for patients suffering from debilitating diseases. The company is based in Lexington, MA. The CEO of the company is Sanj K. Patel. | Health Technology |
- Börse
- Insiders
- Barry Quart
- Erfahrung
